Tauroursodeoxycholic acid inhibits experimental colitis by preventing early intestinal epithelial cell death
- 1 December 2014
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 94 (12) , 1419-1430
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- iNOS-Dependent Increase in Colonic Mucus Thickness in DSS-Colitic RatsPLOS ONE, 2013
- Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNFEMBO Molecular Medicine, 2013
- p53 Mediates TNF-Induced Epithelial Cell Apoptosis in IBDThe American Journal of Pathology, 2012
- Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel diseaseGut, 2011
- Tauroursodeoxycholic Acid (TUDCA) Protects Photoreceptors from Cell Death after Experimental Retinal DetachmentPLOS ONE, 2011
- Structure–function analysis of the tertiary bile acid TUDCA for the resolution of endoplasmic reticulum stress in intestinal epithelial cellsBiochemical and Biophysical Research Communications, 2011
- Bile acids: regulation of apoptosis by ursodeoxycholic acidJournal of Lipid Research, 2009
- Positive Role of CCAAT/Enhancer-Binding Protein Homologous Protein, a Transcription Factor Involved in the Endoplasmic Reticulum Stress Response in the Development of ColitisThe American Journal of Pathology, 2009
- Signaling pathway via TNF-α/NF-κB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- The role of membrane cholesterol in determining bile acid cytotoxicity and cytoprotection of ursodeoxycholic acidBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009